Next Article in Journal
Structural Insights into the Iodothyronine Deiodinase 2 Catalytic Core and Deiodinase Catalysis and Dimerization
Next Article in Special Issue
Role of Sex and Early Life Stress Experience on Porcine Cardiac and Brain Tissue Expression of the Oxytocin and H2S Systems
Previous Article in Journal
Evolution During Bottle Ageing of Wines Macerated with Toasted Vine-Shoots and Micro-Oxygenation
Previous Article in Special Issue
Circular RNA in Cardiovascular Diseases: Biogenesis, Function and Application
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Using a Failing Human Ventricular Cardiomyocyte Model to Re-Evaluate Ca2+ Cycling, Voltage Dependence, and Spark Characteristics

by
Jerome Anthony E. Alvarez
1,2,
Mohsin Saleet Jafri
1,3,* and
Aman Ullah
1,*
1
School of Systems Biology, George Mason University, Fairfax, VA 22030, USA
2
US Naval Research Laboratory, Center for Bio/Molecular Science and Engineering, Washington, DC 20375, USA
3
Center for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, MD 20201, USA
*
Authors to whom correspondence should be addressed.
Biomolecules 2024, 14(11), 1371; https://doi.org/10.3390/biom14111371
Submission received: 31 August 2024 / Revised: 13 October 2024 / Accepted: 23 October 2024 / Published: 28 October 2024

Abstract

:
Previous studies have observed alterations in excitation–contraction (EC) coupling during end-stage heart failure that include action potential and calcium (Ca2+) transient prolongation and a reduction of the Ca2+ transient amplitude. Underlying these phenomena are the downregulation of potassium (K+) currents, downregulation of the sarcoplasmic reticulum Ca2+ ATPase (SERCA), increase Ca2+ sensitivity of the ryanodine receptor, and the upregulation of the sodium–calcium (Na=-Ca2+) exchanger. However, in human heart failure (HF), debate continues about the relative contributions of the changes in calcium handling vs. the changes in the membrane currents. To understand the consequences of the above changes, they are incorporated into a computational human ventricular myocyte HF model that can explore the contributions of the spontaneous Ca2+ release from the sarcoplasmic reticulum (SR). The reduction of transient outward K+ current (Ito) is the main membrane current contributor to the decrease in RyR2 open probability and L-type calcium channel (LCC) density which emphasizes its importance to phase 1 of the action potential (AP) shape and duration (APD). During current-clamp conditions, RyR2 hyperphosphorylation exhibits the least amount of Ca2+ release from the SR into the cytosol and SR Ca2+ fractional release during a dynamic slow–rapid–slow (0.5–2.5–0.5 Hz) pacing, but it displays the most abundant and more lasting Ca2+ sparks two-fold longer than a normal cell. On the other hand, under voltage-clamp conditions, HF by decreased SERCA and upregulated INCX show the least SR Ca2+ uptake and EC coupling gain, as compared to HF by hyperphosphorylated RyR2s. Overall, this study demonstrates that the (a) combined effect of SERCA and NCX, and the (b) RyR2 dysfunction, along with the downregulation of the cardiomyocyte’s potassium currents, could substantially contribute to Ca2+ mishandling at the spark level that leads to heart failure.

1. Introduction

The complex and coordinated mechanism of calcium-induced calcium release (CICR) in ventricular cardiomyocytes has been rigorously studied to better understand the processes behind excitation–contraction coupling (ECC) in cardiac cells [1]. In a healthy human heart, the process of contraction starts with the opening of the voltage-dependent calcium (Ca2+) channels also called dihydropyridine receptors (DHPRs) or the L-type calcium channel (ILCC). The opening of DHPRs with depolarization, however, is insufficient to induce a full contraction. This small influx of Ca2+ from the ILCC induces a Ca2+ release from the sarcoplasmic reticulum (SR) through the ryanodine receptors (RyR2s) in a process termed calcium-induced calcium release (CICR). This depolarizing Ca2+ influx in CICR activates the RyR2s which release Ca2+ from the sarcoplasmic reticulum into the myoplasm ([Ca2+]myo) which results in a myocyte contraction through the shortening of the sarcomere. In the repolarization process, SR Ca2+ levels are then re-sequestered by the SR Ca2+–ATPase (SERCA) from the myoplasm. Excess Ca2+ is further extruded from the myoplasm by the sodium–calcium exchanger (Na+–Ca2+; INCX) which renders the cardiac cells into a “relaxed” state.
On the other hand, asynchronous or erratic Ca2+ cycling is a prominent characteristic of a failing human heart. Impaired SERCA function and enhanced INCX activity have been proposed as causes of reduced SR Ca2+ load notable in cases of heart failure (HF) [2]. The dysfunction of Ca2+ dynamics during heart failure leads to early and/or delayed afterdepolarizations (EADs and/or DADs) initiates ventricular arrhythmia [3,4]. These phenomena exhibit secondary depolarization occurring before or after a complete action potential (AP) repolarization. These arrhythmias can lead to ventricular tachycardia which often serves as an immediate precursor to ventricular fibrillation which has been identified as a major cause of sudden cardiac death [5]. While these observations are generally accepted in recent studies, further understanding of excitation–contraction coupling dynamics during these conditions is needed.

Impaired SERCA vs. Hyperphosphorylated RyR2

The mechanisms of heart failure continue to be a subject of discussion and disagreement in the literature. One perspective, as previously mentioned, is the combined effect of decreased SERCA and increased INCX activities. Another is the diastolic SR Ca2+ leak via calstabin2-depleted “leaky” RyR2 channels caused by phosphorylation [2,6]. The latter has been increasingly recognized as an important contributor to altered Ca2+ handling in failing hearts. Relatedly, the amplitude and rate of decay of both contraction and the underlying systolic Ca2+ transient ([Ca2+]i) are reduced [6]. A noteworthy study by Jiang et al. states that RyR2 activities in both failing and healthy human and canine hearts appear structurally and functionally normal, meaning that their differences in RyR open probabilities are not statistically significant [7]. This is also supported by the findings of Stange et al. wherein single site RyR2 phosphorylation does not substantially change between wild-type and mutant RyR2s [8]. Moreover, studies by Lehnart et al. and Marx et al. suggest that hyperphosphorylated RyR2 channels are associated with cardiac dysfunction and arrhythmias which overall contributes to defective Ca2+ regulation in failing hearts [9,10]. Ultimately, the mechanisms behind the reduction of SR Ca2+ content and impaired cardiac contractility can be traced from the following: (a) the impaired SERCA activity accompanied by increased INCX, (b) an increased Ca2+–RyR2 sensitivity or hyperphosphorylated RyR2 channels, or (c) both conspiring to deplete the SR Ca2+ [2,11]. Ultimately, the mechanisms behind the reduction of SR Ca2+ content and impaired cardiac contractility can be traced from: (a) the impaired SERCA activity accompanied by increased INCX, (b) an increased Ca2+–RyR2 sensitivity or hyperphosphorylated RyR2 channels, or (c) both conspiring to deplete the SR Ca2+ [2,11]. A reevaluation of these factors is emphasized and suggested by the works of Eisner and Trafford [6].
Although multiple observations have been reported in targeting principal mechanisms of heart failure, further investigation at the level of the Ca2+ spark is needed. This study presents an overall comparison of Ca2+ dynamics and sparks between SERCA/NCX and RyR2 phosphorylation in failing human ventricular cardiomyocytes, along with its attributable changes in AP morphology and EC coupling gain. The force–frequency relationship between healthy and failing hearts through predicted steady-state force and SR fractional release are also further explored in this research.

2. Materials and Methods

2.1. Model

Simulations were performed using a previously published stochastic human ventricular cardiomyocyte model [12]. The cardiomyocyte’s calcium-release units (CRUs) in the cardiac dyad consist of L-type calcium channels (LCCs) in t-tubules which are co-localized with ryanodine receptors (RyR2s; type 2 in cardiac cells) in a junctional SR (JSR) membrane. The 20,000 CRUs in this model are composed of 9 individual LCCs and 49 RyRs that function as couplons and they are intricately connected through the complex organization of the network SR (NSR) which stores the main intracellular calcium in cardiac muscle cells. Moreover, the excitation–contraction coupling scheme incorporates 3-state RyR and 6-state L-type Ca2+ channel mode switching that adapt to various calcium dynamics and action potential morphology consistent with experimental findings (see [12] for further details).

2.2. Statistical Analysis

Analysis of Variance (ANOVA) and pairwise comparisons using Student’s paired t-Tests as specified were conducted using Microsoft Excel (Redmond, WA, USA). Figures were generated using R Software’s (version 2023.06.1, Vienna, Austria) base, stats, and ggplot2 packages, MATLAB 2016a (Natick MA), and IDL® Software (Ballsbridge, London)—L3HarrisGeospatial. Statistical tests were considered statistically significant at p < 0.05.

2.3. Pacing Protocol

Simulations and analyses were performed at 1 Hz for 20 s to achieve steady state unless specified otherwise. Dynamic pacing was conducted using slow–rapid–slow pacing at 0.5 Hz–2.5 Hz–0.5 Hz for determining the force–frequency relationship. Voltage-clamp experiments were conducted in both control and heart-failure conditions: measurements of Ca2+ dynamics were activated by a series of 0.2 s depolarizing steps (VTest) from −40 to +30 mV in increments of 5 mV.

2.4. Force–Frequency Relationship and SR Ca2+ Fractional Release

Sun and Irving [13] described the molecular basis of the force–calcium relation in the heart muscle. Changes in [Ca2+]i can directly affect cardiac contractility which helps distinguishing factors in a defective cardiac cell. The co-operative mechanism of Ca2+ dependence in force generation was shown to be an intrinsic property of the thin filaments (i.e., actin, tropomyosin, troponin) during contraction. This Ca2+ dependence of isometric force generation was experimentally observed using demembranated ventricular trabeculae by Sun et al. [14] The predicted force using intracellular Ca2+ is described by the Hill equation:
f o r c e = 1 1 + 10 n H ( p C a p C a 50 )
where n H (ranging 3 to 4) is the Hill coefficient, pCa represents peak systolic [Ca2+]myo in log scale ( p C a = l o g 10 [ C a 2 + ] m y o ) , and p C a 50 (ranging 5.5 to 6.0) corresponds to half-maximum force. For this study, n H = 3 and p C a 50 = 6 were used in computing the predicted force for each peak [Ca2+]myo concentration.
On the other hand, the fraction of the SR Ca2+ content released at a twitch, known as “fractional SR Ca2+ release”, is an important parameter for assessing the efficiency of excitation–contraction coupling under physiological and pathophysiological conditions [15,16]. The global SR Ca2+ depletion amplitudes in both diastolic and systolic phases of the SR Ca2+ are recorded in this study, and the fractional release is computed by:
F r a c t i o n a l   R e l e a s e = [ C a 2 + ] S R , d i a s t o l i c [ C a 2 + ] S R , s y s t o l i c [ C a 2 + ] S R , d i a s t o l i c

3. Results

3.1. Simulated Excitation–Contraction Coupling Changes in Heart Failure

Alterations in Ca2+ handling contribute to diminished contraction and relaxation in the event of heart failure (Figure 1). Ca2+ homeostasis is essential to a normal functioning heart; however, abnormalities in Ca2+ dynamics are key determinants in the development of arrhythmogenic disorders in the failing heart. In CICR, extracellular calcium entry into the cell through ion channels in the T-tubules leads to an increase in calcium concentration in the dyadic subspace. The model in this study examined how subspace [Ca2+]i changes between control and heart-failure conditions by implementing previously observed changes in ion transport proteins [17,18,19]. The overall simulation settings are summarized in Table 1 simulate end-stage heart failure. The K+ currents (Ito, IK1, IKr, and IKs) were downregulated in all cases of failing hearts in this study, specifically ventricular samples from explanted hearts from end-stage HF patients undergoing transplantation and similar cases [20,21,22]. NCX protein expression was increased by 100% and SR Ca2+ ATPase (SERCA) protein was decreased by 30% [19,23]; and RyR2 Ca2+ sensitivity was increased by 50% to mimic increased activity from chronic hyperphosphorylation [9,24,25,26,27]. Overall, these ionic effects lead to impaired cellular functions observed in failing heart cells.
Simulations at 1 Hz pacing displayed APD prolongation and a loss of the distinctive “notch” in the action potential shape during HF similar to the experiment (Figure 1A). Multiple EADs were also observed during a 20 s simulation of heart failure under slow 0.5 Hz pacing (Appendix A Figure A1) which was also demonstrated by Li and colleagues in canine hearts [31] where EADs occur more than 40% on average during a slow 0.5 Hz frequency. On the other hand, myoplasmic Ca2+ concentration displays a slower decay due to attenuated sequestration back to the SR due to reduced SERCA function (Figure 1B); a small “notch” can also be observed in HF (red) and this phenomenon was demonstrated in experimental studies [32,33,34]. The RyR open probability shows decrease peak and more dispersed activation late in the AP under HF conditions (Figure 1C) which is further discussed in the next section. Lastly, because SR Ca2+ influx is directly influenced by SERCA in transporting Ca2+ from the myoplasm—the SERCA is impaired in this case—overall levels of SR Ca2+ concentration are decreased (Figure 1D), which can account for the reduced RyR open probability in spite of the increased Ca2+ sensitivity because of RyR phosphorylation. Furthermore, the decreased SR Ca2+ content also reduces the driving force for Ca2+, contributing to the reduced amplitude of the Ca2+ transient (Figure 1B). These results are consistent with the early work of Vermeulen and colleagues [35,36] using human ventricular trabeculae from patients with terminal heart failure and further simulation studies from Priebe and Beuckelmann [37].

3.2. Contributions of K+ Currents to Heart-Failure Phenotype

Several experimental studies have shown varying degrees of protein expression of the repolarizing K+ currents in end-stage, diseased, and failing human ventricular cells [20,22,28]. Specifically, the inward rectifying (IK1), transient outward (Ito), and the slow delayed rectifier (IKs) K+ currents are downregulated in all cases of cells exhibiting abnormal histology. The downregulation of the rapid delayed rectifier (IKr) K+ current in failing human ventricular myocytes remains controversial in the literature due to statistically non-significant results, but nevertheless, a shift in the hERG1a:hERG1b isoform stoichiometry at the protein level was observed [22] (further analysis of this case is explained in Section 4. Discussion). This study therefore includes its potentially arrhythmogenic contribution to APD prolongation.
The differential expressions from the reported voltage-dependent K+ currents in heart failure could provide defining characteristics in the action potential and calcium dynamic profiles in cardiac cells. From the data in Table 1, each respective downregulation of the K+ currents was factored into the reduction of conductance without the effects of SERCA, INCX, and RyR modulations (Figure 2A). All K+ current blocks can potentially prolong the APD, but Ito shows a prominent effect on the “notch”, which is a distinctive feature of the human AP. This effect is expected because Ito is responsible for the repolarizing current in phase 1 of the action potential, but its other consequences are also observed in other channels and cellular Ca2+ concentrations.
One of the known arrhythmia mechanisms in cardiac hypertrophy and heart failure is a slowed Ca2+ transient [38,39]. However, there is little information on the possible effects of K+ currents in the prolonged time-to-peak of intracellular Ca2+ from the SR. Hence, we tested each of the K+ current modifications as previously stated in Table 1 simulation settings. We observed that Ito shows a notable effect on slowed time-to-peak Ca2+ transient from ~0.02 to ~0.04 s (Figure 2B). ILCC peak density also decreased approximately 30–35% (Figure 2C) from the effects of downregulated Ito alone. This occurs because the loss of the notch (increased membrane potential) reduces the driving force for Ca2+. Moreover, the reduction in ILCC reduces the number of dyads activated and thus reduces RyR2 open probability by ~20–25% (Figure 2D). This contributes to the delayed kinetics of SR Ca2+ release into the cytosol (Figure 2E) and occurs mainly through the reduction in Ito compared with other repolarizing currents.
Figure 3 explores force–interval relations. Because of the decreased repolarizing K+ currents shown in Figure 2B, the Ca2+ transient also exhibits a small increase in amplitude, with the exception of Ito’s effects (in blue). The APD is generally prolonged due to these effects and more Ca2+ is transported inside the cell.
The next set of simulations uses the slow–rapid–slow pacing (0.5–2.5–0.5 Hz) protocol to explore excitation–contraction coupling potentiation during rapid pacing. In the context of Ca2+ dependence of isometric force generation using peak systolic [Ca2+]myo (Equation (1)), dynamic slow–rapid–slow pacing (Figure 3) shows that the potentiation of the Ca2+ transient and force that occurs with rapid pacing is attenuated with the changes to RyR sensitivity, SERCA, and NCX (red) vs. normal healthy myocytes. The changes in the membrane K+ current attenuates the potentiation during the rapid pacing at 2.5 Hz. High pacing of 2.5 Hz was chosen as the peak frequency for this simulation, which was observed to reach the maximal developed force in humans from experimental recordings [40].

3.3. RyR2 Hyperphosphorylation vs. Impaired SERCA and Upregulated NCX

Competing hypotheses of key determinants in the altered Ca2+ cycling of failing hearts have long been debated. Maladaptive protein kinase hyperphosphorylation of RyR2 in failing hearts alters channel function, which may cause SR Ca2+ depletion and its diastolic release [2]. On the other hand, the widespread agreement in earlier studies suggests that a decreased SR Ca2+ content was due to a decrease in SERCA coupled with an increase in NCX, which decreases the capacity of the SR to accumulate calcium [41]. However, they suggest that the relative contributions of changes of SERCA and RyR2 to heart failure be reevaluated [6], which will was done in this study.
In pathological conditions of failing hearts, substantial evidence suggests that cardiac contractility is associated with the reduction in SR Ca2+ at the cellular level [3,42,43,44]. However, little is known about its consequences for the functionality of the calcium-releasing units (CRUs). The next set of simulations in Figure 4 compares normal healthy myocytes to failing myocytes (red) compared to normal healthy myocyes (black). There are contributions for each of the changes to Ca2+ dynamics (increased RyR Ca2+ sensitivity, decreased SERCA expression, and increased NCX expression). In each of the simulations, the changes (except Normal) to the K+ current are included. RyR open probability and ILCC density are decreased (Figure 4A and Figure 4B, respectively). Furthermore, because hyperphosphorylated RyR2s is a known physiological abnormality in HF, its activity is presumed to have direct anomalous behavior as part of the CRU. Therefore, peak amplitudes of RyR2 open probability and the ILCC current were measured (Figure 4C and Figure 4D, respectively). We observe that the increased RyR sensitivity can decrease L-type calcium channel density (Figure 4D, blue bar) more than its own open fraction (Figure 4C, blue bar). A single-factor ANOVA test for independent measures also reveals that each of the HF-related changes of measured RyR and LCC amplitudes are significantly different (p < 0.05) from a normally functioning CRU. On the other hand, it is important to note that the overall Ca2+ levels in SR are decreased in HF. However, variation in levels of SR Ca2+ concentrations are consistent with each of the effects of hyperphosphorylated RyR2 versus impaired SERCA, and NCX (Figure 4E). It could also be inferred that the ILCC peaks (Figure 4D) affect the allowable Ca2+ released by the SR during systole—the lowest peak of ILCC by phosphorylated RyR alone also corresponds to the least SR flux into the cytosol (Figure 4E).
In order to generalize this inference, we applied the same dynamic slow–rapid–slow pacing (0.5–2.5–0.5 Hz) in the network SR with the same isolated mechanisms (Figure 5): normal cardiomyocyte (Figure 5A), decreased SERCA activity and upregulated NCX (Figure 5B), hyperphosphorylated RyR2 (Figure 5C), combination of both cases (Figure 5D), and each of their respective SR Ca2+ fractional releases (Figure 5E). Once again, in all cases except Normal, the K+ changes reflect those seen in HF. On an important note, a diminished Bowditch or staircase phenomenon is a hallmark of heart failure [45]. This diminished Bowditch effect is observed in Figure 5B,D, largely caused by the downregulated SERCA and upregulated NCX.

3.4. Voltage Dependence and ECC Gain

Gain is commonly referred to as a CICR amplification factor assessed through voltage dependence of affected currents and Ca2+ transients in the myoplasm [46]. Furthermore, it has been previously demonstrated experimentally that altered SR Ca2+ content can dramatically affect E-C coupling gain [47], and this phenomenon was presumed to be an effect of intra-SR Ca2+ on RyR2 gating [48]. Through a voltage-clamp protocol of 0.2 s depolarizing steps (VTest) from −40 to +30 mV, various SR Ca2+ fluxes and associated currents were obtained. Under voltage-clamp conditions, it shows that (1) hyperphosphorylated RyRs contribute more to the SR Ca2+ release flux than (2) upregulated INCX and decreased SERCA activity, and (3) all combined cases (i.e., hyperphosphorylated RyR, upregulated INCX, and decreased SERCA) for HF (Figure 6A). It is important to note that the contraction of striated muscle is triggered by the opening of RyR Ca2+ release channels in the SR membrane in response to depolarization of the transverse invaginations of the plasma membrane by the T-tubules [49]. Hence, increased sensitivity of RyR2s in the heart muscle during the varying degrees of incremental increase in voltage is expected to release more Ca2+ from the SR.
On the other hand, E-C coupling in cardiac cells occurs by CICR where a small Ca2+ current (ICa,L) through the L-type Ca2+ channels locally controls a larger Ca2+ release from the SR via RyR2s [50]. In the early studies of failing rabbit heart cells, ICa,L’s current is decreased from −10 mV to positive membrane potentials due to the upregulation of INCX [51]. This phenomenon was observed in simulated HF; however, the ICa,L current can also increase in hyperphosphorylated RyR2s (Figure 6B). Data on ICa,L has been reviewed in detail in early studies of Hart [52] which described that ICa,L may be increased in mild hypertrophy, unchanged in moderate degrees of hypertrophy, and reduced in severe hypertrophy with failure [53]. Although the relationship between mechanisms of ECC gain and ICa,L’s voltage dependence cannot be directly attributed to the cases of hypertrophied hearts, this could be an area of research worth pursuing.
The measurement of excitation–contraction coupling gain is computed as the ratio of peak SR Ca2+ release flux and the peak flux of [Ca2+]i across the cell membrane [47,54,55]. This study aims to differentiate each HF’s underlying mechanism and the measurement of the EC coupling gain shows that increased RyR2 sensitivity corresponds to the highest gain in negative membrane potentials (Figure 6C). Changes in gain with other pathological and experimental conditions have been used to make inferences about the microscopic structures responsible for Ca2+ sparks [50], and more importantly, defective EC coupling cardiac hypertrophy and heart failure has been previously described [56] (relative characteristics of calcium sparks are discussed in the next section).
Hyperphosphorylation of RyR2s also minimally affects its open probability (Figure 6D). This statistically insignificant finding was previously reported by Jiang et al. [7] in the experimental recordings of failing canine and human hearts. To further support this finding, we conducted paired Student’s t-tests to mimic an experimental situation of a failing human cardiac cell from a single sample with different HF conditions, and all yielded to insignificant results (p > 0.05). This minimal effect to the RyR open fraction is because RyR activation is not sensitive to levels of Ca2+, but rather to their (a) proximity to the L-Type calcium channels [57], and (b) RyR2 adaptability when exposed to higher Ca2+ [58].
Moreover, because human cardiac cells rely on the SERCA pump to a lesser degree (~60%) than rodents (~90%), limited information is known in the direct implication of a reduction in SERCA activity in human failing hearts for overall contractile function [59]. This study demonstrates that the voltage dependence of SR Ca2+ reuptake by SERCA is directly related to its functionality, wherein the 50% reduction in SERCA activity in HF accounts for the least sequestration of Ca2+ back into the SR (Figure 6E, green line). And as previously described in Figure 4E, SR Ca2+ content is generally reduced in failing hearts and its systolic levels can vary with each underlying pathophysiological condition (Figure 6F).

3.5. Calcium Sparks in Failing Hearts

Ca2+ sparks are discretized calcium release events due to random and collective openings of the RyR2 channels clustered in a calcium release unit (CRU). On a fundamental level, these sparks result from spontaneous openings of single SR calcium-release channels supported by ryanodine-dependent changes of spark kinetics [60]. The RyR is both the SR Ca2+ release channel and a scaffolding protein that localizes key regulatory proteins such as calmodulin, calsequestrin, and other proteins at the luminal SR surface [1]. Local CRU Ca2+ sparks were investigated using the mathematical model of Williams et al. [61] which includes spatial nanodomain determinants of individual CRU organization and a realistic number of 20,000 CRUs. The systolic [Ca2+]i transient activates L-type Ca2+ channels at the surface membrane and at transverse tubules, which then elevates [Ca2+]i locally in the dyadic subspace compartment between the t-tubular and terminal SR membranes. This situation is amplified when RyR2 clusters are activated by a locally elevated subspace [Ca2+]i during CICR (see ref. [62] for a physiological review). This spontaneous local increase in intracellular calcium concentration from the SR produces calcium sparks (Figure 7A).
On the other hand, in early studies of cardiomyopathic ventricular cells, it was determined that failing ventricular cells were intrinsically predisposed to early afterdepolarizations and spontaneous depolarizations [63,64]. EADs have been linked to the pathogenesis of long Q-T syndrome and this reflects an increased propensity for abnormal repolarization and prolonged APD-related arrhythmias [63]. Computational studies suggest that the changes in heart failure, such as APD prolongation and an increase in late phase of Ca2+ release during AP, result in an increased diastolic spark rate [65] (Figure 7B). To illustrate this phenomenon, we paced the HF model in 0.5 Hz because the occurrence of EADs is at least 40% higher in lower pacing observed in failing cardiomyocytes [31] (Appendix A Figure A1).
Early investigations have emphasized that each RyR cluster is associated with multiple LCCs observed in both rat and rabbit ventricular cells [50,66,67], and results suggest that the small ICaL could be a highly effective trigger of SR Ca2+ release. Accompanied during this SR Ca2+ release is the occurrence of calcium sparks which was discovered through the ryanodine-dependent changes of spark kinetics [60]. During systole in HF, SR Ca2+ levels are generally decreased (Figure 8A). However, differences in the average number of sparks seem to depend on the underlying pathophysiological condition in HF. Increased RyR2 sensitivity exhibits the most abundant number of sparks (Figure 8B) and displays a more lasting duration by two-fold longer than a normal cell (Figure 8C). This longer duration could also be related to prolonged Ca2+ transient (see Appendix A Figure A2 for simulation results). In contrast, there is little or no notable difference among all the HF mechanisms on each respective average spark peak (Figure 8D). On the same note, the variability of spark characteristics observed during K+ block conditions only (devoid of SERCA, INCX, and RyR dysfunction) are negligible (Appendix A Figure A3).

4. Discussion

In cardiac-modeling studies, the increase in spontaneous Ca2+ leak in failing hearts is simulated mainly through the increase in SR Ca2+ release by hyperphosphorylated RyR2, decreased outward potassium currents, and impaired calcium-extruding pumps such as SERCA and NCX. Accompanied with the reduced K+ currents, the cell then becomes oversaturated with Ca2+, which prolongs the APD, and the increase in cytosolic calcium is caused by the excessive calcium entry and reduced calcium efflux [68]. In contrast, decreased RyR2 mRNA expressions were also observed in failing human hearts [69,70,71] which helps explain the reduction of RyR2 open probability. Furthermore, in the context of calcium dynamics, it was observed by Arnáiz-Cot and colleagues [72] that the heart failure due to defective RyR2 led to a longer calcium transient decay, longer spark duration, and decreased spark peak, which prove to be consistent in this study.

4.1. SERCA and INCX vs. RyR: Alterations in SR Ca2+ Content

The presence of EADs at low pacing (0.5 Hz) is also possible throughout the oscillation of the membrane potential which re-depolarizes the myocyte due to the reduced outward currents. If spontaneous CICR from the SR occurs before repolarization is complete, the consequent stimulation of inward INCX may oppose and reverse repolarization [73]. In comparison, SERCA transports two Ca2+ ions per ATP consumed, whereas extrusion by NCX only pumps one Ca2+. The shift in competition from the SR Ca2+-ATPase toward NCX also tends to limit SR Ca2+ loading in heart failure [74], hence lowering SR Ca2+ content recovery. Moreover, it was previously observed in experiments using isolated RNA human left ventricular myocardium of 30 cardiac transplant recipients with end-stage heart failure [75] that the overall expression of SERCA mRNA was diminished by 50%, thus altering the Ca2+ handling that contributes to systolic and diastolic dysfunction in heart failure patients.
During heart failure, RyR2s are hyperphosphorylated, which increases their sensitivity to Ca2+. In the model, this is simulated by increasing the Ca2+ sensitive RyR opening rate, thereby increasing open probability for a given subspace and SR Ca2+ level. However, with the increased RyR open probability, there is more Ca2+ leak out of the SR, reducing the SR load as shown by this model (Figure 2E black vs. blue traces and in previous modeling and experimental work) [2,5,6,61,76]. A decrease in SR Ca2+ load can lead to a decreased probability of sparks. In the simulations, there is a reduction in the peak RyR open probability, but an increase in the RyR open probability (and number of Ca2+ sparks) late in the action potential and during diastole. Hence, the total number of Ca2+ sparks and non-spark leak increases in spite of a reduction in peak RyR open probability during the AP.
Previously reported evidence suggests that cardiac contraction would be further reduced if it were not for concomitant modulations to RyR2s, which sensitize release clusters to release Ca2+ [77]. These SR Ca2+ alterations were observed and reported to increase Ca2+ spark frequency and fractional SR Ca2+ release during ECC in failing cardiomyocytes as compared to healthy cells [78,79,80]. On the other hand, Kubalova et al. reported that an event of diminished SR Ca2+ release in failing myocardium could be explained by the increased sensitivity of RyR2s [80]. From Figure 5B, this study shows that SR Ca2+ fractional release could be altered depending on the impairment of calcium-related proteins—(a) diminished SERCA function and enhanced INCX can increase SR fractional release while (b) increased sensitivity of RyR2s can decrease it. Determining these phenomena could provide a therapeutic advantage for drug targets.
EC coupling gain was clearly altered at negative membrane potentials by changes in SR Ca2+ content and fluxes. Other studies have also reported altered E-C coupling gain independent of SR Ca2+ load, although this was not considered a universal finding [81]; pirfenidone treatment for human pulmonary fibrosis increases ILCC expression by twofold and was shown to increase ECC gain at negative potentials [82]. This study suggests that ECC gain can also be increased by hyperphosphorylation of RyR2s as suggested by the results of voltage-clamp experiments. As pointed out by Trafford et al. [83], sudden increase or decrease in Ca2+ release through the RyR2 for a given stimulus will cause alterations in the SR Ca2+ load. The increase in L-type Ca2+ current also increases the Ca2+ entry into the cell, with a resulting higher SR Ca2+ content which was also observed experimentally in rat and ferret ventricular myocytes [84]. In the context of Timothy syndrome (LQT type 8), a disease caused by a gain-of-function mutation in the L-type calcium channels [85], Ca2+ influx is increased, which also prolongs the APD that causes arrhythmogenic effects. It was demonstrated by Drum et al. [86] in LQT-8 mouse ventricular cells that even small alterations to the LCCs were sufficient to induce maximal changes in resting systolic and diastolic intracellular calcium, which eventually resulted into an increased SR Ca2+ load and increased ECC gain.

4.2. Importance of Transient Outward Potassium Current (Ito) Effects

AP morphology and duration are directly influenced by the inward and outward currents, and these current abnormalities have been comprehensively described in human heart-failure experiments [38,53]. Several studies examining Ito in heart failure used calcium-buffered internal solutions, which eliminates any possible role of calcium-dependent processes [38] and multiple pieces of evidence suggest that Ito can also influence overall action potential duration [28,63,87]. Moreover, it was observed that Ito downregulation in failing left and right ventricular human cardiac cells accounts for the diminished phase 1 repolarization of the action potential [20,88] and multiple diseases stemming from this altered Ito function have also been reported [89,90]. The cause of Ito changes has been linked to changes in transcription factor activation [91]. The model simulations show that with the reduction in Ito the notch in the AP disappears, leading to increased membrane potential when the peak L-type Ca2+ occurs. With the increased membrane potential, there is less driving force for Ca2+, thereby reducing the peak L-type Ca2+ current. This leads to less triggered RyR activity, further impacting Ca2+ dynamics. This research also demonstrates that Ito downregulation, other than the expected loss of “notch” in the action potential, can also lead to slower time-to-peak transfer of calcium to the cytoplasm. This kinetic trait was experimentally recorded and observed as a slowed Ca2+ transient under the conditions of hypertrophy or heart failure [38,39].

4.3. Limitations

4.3.1. Rapid Delayed Rectifier Potassium Current (IKr) Downregulation

The downregulation of IKr in failing human cardiac cells is currently being debated and its experimental evidence is still undergoing investigation. Its protein expressions from animal heart-failure models were reported to be inconsistent: felines with hypertrophy and rabbits on pacing-induced HF were observed to have significantly lower IKr expression than normal left ventricular cells [92,93], while, on the other hand, rats, guinea-pigs, and canines show no changes [31,94,95]. Recently, Holzem et al. [22] observed that in failing human left ventricular cell, they found no statistically significant differences in the mRNA expression levels when comparing failing to donor human heart tissue. However, they did emphasize in their experiments that IKr is functionally downregulated in human heart failure—the hERG1a mature protein had a 0.55-fold reduction (p = 0.51) in the epicardium of failing compared with healthy hearts and total hERG1a protein trended toward reduction. Moreover, the stoichiometry of hERG1a:hERG1b isoforms was altered in failing versus donor hearts, with 0.58-fold reduction in the epicardium. Another perspective involves cardiac safety—the analysis of IKr blocking effects in associative risk of drug-induced arrhythmia is mandatory in the development of new drugs [21,96]. Therefore, we slightly decreased the conductance of IKr in this study to emulate a modest contribution to APD prolongation as seen in experimental findings.

4.3.2. Other Ionic Currents Present in Heart Failure

Several alterations seen in ionic current behaviors and Ca2+ regulatory proteins were previously described in multiple cases of hypertrophy and heart failure. For example, a mutation in the CACNA1C gene encoding the L-type calcium channel (ILCC) was associated with reduced voltage-dependent inactivation and displayed a propensity for arrhythmogenesis [97]. Another example is that the functional changes, especially in the gain-of-function, of the late sodium current (INa) inhibition were considered a major contributor to electrophysiological and calcium dynamic abnormalities from patients with human hypertrophic cardiomyopathy (HCM) [98]. However, this study focused on the contributions of the K+ currents and other calcium regulatory proteins such as SERCA, RyR, and the sodium–calcium exchanger (INCX) due to their relative contribution to repolarization and prolonged APD.
It was previously described by Tomaselli et al. [38] that there is a dispersion of action potential duration in the ventricle of both man [99] and animals [100] and it is possible that changes in the expression of K+ currents could enhance this dispersion of action potential repolarization. In the ventricular action potential, IKs is a major contributor to the ventricular “repolarization reserve” by providing a redundant current to maintain rapid repolarization during increases in cardiac rate or during conditions in which other ventricular potassium currents are reduced, specifically the IKr current in humans [101]. From a spatial perspective, Q-T interval dispersion accompanied in sudden expected death in chronic heart failure has been reported [102]. Temporally, the beat-to-beat Q-T interval variability was also evidently described in ischemic and non-ischemic dilated cardiomyopathy, which reflects withdrawal of parasympathetic tone accompanying heart failure [103]. Potassium currents are responsible for the repolarization of the cardiac action potential, and spatial and temporal dispersion of repolarization are altered in the failing human heart. This dispersion of repolarization has a major role in long Q-T, short Q-T, and Brugada syndromes and may also underlie polymorphic ventricular tachycardia and ventricular fibrillation [38,104,105,106].

4.3.3. T-Tubule-Remodeling During Heart Failure

In HF cardiomyocytes, the rising phase of the Ca2+ transient is slower than healthy cells which contributes to its impaired contractility. It was previously reported by Louch et al. that dyssynchronous Ca2+ transients in failing mouse ventricular myocytes results in a subset of Ca2+ sparks with slow kinetics and they suggest that this observation is predicted to be the result of the reorganization of the calcium release units [107]. They also report that these slowed sparks occur at intact failing cardiac dyads and not in orphaned RyR2s. In mice, a re-organization of the t-tubular systems and orphaning of the RyRs (decoupling form the L-type Ca2+ channels in the dyad) observed by Wagner and co-workers was shown to provide a local mechanism for delayed subcellular Ca2+ release and action potential prolongation through computational modeling [17]. However, although in human heart ventricular myocytes the t-tubular system is not as dense as in rodents, there are still changes seen in heart failure [108]. In dog and pig hearts, which have a more similar AP to human than rodents, there is a large number of areas of the healthy ventricular myocyte showing low t-tubule density. However, similar studies in healthy human hearts are scarce [108,109]. In one such study, Lyu and colleagues observed t-tubule remodeling and RyR orphaning in aging otherwise healthy human hearts [110]. On the other hand, a recent study by Seidel and co-workers used samples from end-stage HF patients undergoing left ventricular assist device surgery [111]. The patients were stratified into two groups, one that had ejection fraction improvement before surgery and one that did not. The group showing no improvement after surgery had decreased t-tubule density and RyR orphaning compared to the group that showed ejection fraction improvement after surgery. In the group with t-tubule remodeling, there the Ca2+ transient was delayed and more asynchronous, similar to the modeling predictions of Wagner and co-workers in rats [17]. In fact, Wei and co-workers have suggested that t-tubule remodeling is crucial for the transition from ventricular hypertrophy to heart failure [112]. In Figure 8, this study also demonstrates that the slowed kinetics and higher occurrences of calcium sparks in failing hearts are largely influenced by the altered RyR2 function through increased sensitivity. Relatedly, however, potassium current blockade as described in Figure 2 minimally contributes to the overall spark characteristics of failing hearts. Therefore, this insight prompts the importance of investigating abnormal CRU reorganization at a cellular perspective in future studies.

5. Conclusions

Diseased or failing hearts are known to pathologically regulate a wide variety of ion channels and Ca2+-handling proteins, which eventually contribute to their associated ventricular arrhythmogenesis. Alterations in contraction and relaxation of failing hearts can be directly associated with corresponding alterations in Ca2+ cycling. Specifically, this study demonstrates that SERCA, NCX, and RyR2 dysfunction, along with the downregulation of the cardiomyocyte’s potassium currents, could substantially contribute to heart failure. Despite major progress in cardiovascular studies, heart failure still remains one of the leading causes of death. Therefore, early detection of defective cardiac cell behavior is crucial for preemptive onsets of abnormal cardiac contractility and overall help mitigate this life-threatening disease.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/biom14111371/s1, HF Supplementary Materials.rar.

Author Contributions

Conceptualization, J.A.E.A., M.S.J. and A.U.; methodology, J.A.E.A., M.S.J. and A.U.; software, J.A.E.A. and A.U.; validation, J.A.E.A., M.S.J. and A.U.; formal analysis, J.A.E.A.; investigation, J.A.E.A.; resources, M.S.J.; writing—original draft preparation, J.A.E.A.; writing—review and editing, J.A.E.A., M.S.J. and A.U.; visualization, J.A.E.A.; supervision, M.S.J. and A.U. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Model code is available in the Supplemental Material. The authors should be contacted for any other data or help with the code.

Conflicts of Interest

The authors declare no conflicts of interest.

Appendix A

Figure A1. Early afterdepolarizations. Remodeled HF is paced at 0.5 Hz to induce EADs. Five EADs were observed throughout the 20 s simulated HF.
Figure A1. Early afterdepolarizations. Remodeled HF is paced at 0.5 Hz to induce EADs. Five EADs were observed throughout the 20 s simulated HF.
Biomolecules 14 01371 g0a1
Figure A2. Simulation results of various HF conditions. RyR hyperphosphorylation (blue) displays more distinctive characteristics, especially in the prolonged calcium transient.
Figure A2. Simulation results of various HF conditions. RyR hyperphosphorylation (blue) displays more distinctive characteristics, especially in the prolonged calcium transient.
Biomolecules 14 01371 g0a2
Figure A3. Comparisons of spark characteristics of normal versus each respective K+ block. (AD) The differences in spark characteristics are negligible in all cases of downregulated repolarizing K+ currents.
Figure A3. Comparisons of spark characteristics of normal versus each respective K+ block. (AD) The differences in spark characteristics are negligible in all cases of downregulated repolarizing K+ currents.
Biomolecules 14 01371 g0a3

References

  1. Bers, D.M. Cardiac excitation–contraction coupling. Nature 2002, 415, 198–205. [Google Scholar] [CrossRef] [PubMed]
  2. Marks, A.R. Calcium cycling proteins and heart failure: Mechanisms and therapeutics. J. Clin. Investig. 2013, 123, 46–52. [Google Scholar] [CrossRef] [PubMed]
  3. Pogwizd, S.M.; Schlotthauer, K.; Li, L.; Yuan, W.; Bers, D.M. Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual β-adrenergic responsiveness. Circ. Res. 2001, 88, 1159–1167. [Google Scholar] [CrossRef]
  4. Lou, Q.; Janardhan, A.; Efimov, I.R. Remodeling of calcium handling in human heart failure. Adv. Exp. Med. Biol. 2012, 740, 1145–1174. [Google Scholar] [CrossRef]
  5. Bers, D.M. Calcium and Cardiac Rhythms. Circ. Res. 2002, 90, 14–17. [Google Scholar] [CrossRef]
  6. Eisner, D.A.; Trafford, A.W. Heart Failure and the Ryanodine Receptor. Circ. Res. 2002, 91, 979–981. [Google Scholar] [CrossRef]
  7. Jiang, M.T.; Lokuta, A.J.; Farrell, E.F.; Wolff, M.R.; Haworth, R.A.; Valdivia, H.H. Abnormal Ca2+ Release, but Normal Ryanodine Receptors, in Canine and Human Heart Failure. Circ. Res. 2002, 91, 1015–1022. [Google Scholar] [CrossRef] [PubMed]
  8. Stange, M.; Xu, L.; Balshaw, D.; Yamaguchi, N.; Meissner, G. Characterization of recombinant skeletal muscle (Ser-2843) and cardiac muscle (Ser-2809) ryanodine receptor phosphorylation mutants. J. Biol. Chem. 2003, 278, 51693–51702. [Google Scholar] [CrossRef]
  9. Lehnart, S.E.; Wehrens, X.H.T.; Reiken, S.; Warrier, S.; Belevych, A.E.; Harvey, R.D.; Richter, W.; Jin, S.L.C.; Conti, M.; Marks, A.R. Phosphodiesterase 4D Deficiency in the Ryanodine-Receptor Complex Promotes Heart Failure and Arrhythmias. Cell 2005, 123, 25–35. [Google Scholar] [CrossRef]
  10. Marx, S.O.; Reiken, S.; Hisamatsu, Y.; Jayaraman, T.; Burkhoff, D.; Rosemblit, N.; Marks, A.R. PKA Phosphorylation Dissociates FKBP12.6 from the Calcium Release Channel (Ryanodine Receptor): Defective Regulation in Failing Hearts. Cell 2000, 101, 365–376. [Google Scholar] [CrossRef]
  11. Lompré, A.-M.; Hajjar, R.J.; Harding, S.E.; Kranias, E.G.; Lohse, M.J.; Marks, A.R. Ca2+ Cycling and New Therapeutic Approaches for Heart Failure. Circulation 2010, 121, 822–830. [Google Scholar] [CrossRef] [PubMed]
  12. Alvarez, J.A.E.; Jafri, M.S.; Ullah, A. Local Control Model of a Human Ventricular Myocyte: An Exploration of Frequency-Dependent Changes and Calcium Sparks. Biomolecules 2023, 13, 1259. [Google Scholar] [CrossRef] [PubMed]
  13. Sun, Y.B.; Irving, M. The molecular basis of the steep force-calcium relation in heart muscle. J. Mol. Cell. Cardiol. 2010, 48, 859–865. [Google Scholar] [CrossRef]
  14. Sun, Y.-B.; Lou, F.; Irving, M. Calcium- and myosin-dependent changes in troponin structure during activation of heart muscle. J. Physiol. 2009, 587, 155–163. [Google Scholar] [CrossRef] [PubMed]
  15. Bassani, J.W.; Yuan, W.; Bers, D.M. Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes. Am. J. Physiol. Cell Physiol. 1995, 268, C1313–C1319. [Google Scholar] [CrossRef]
  16. Bassani, R.A.; Ricardo, R.A.; Bassani, J.W. Estimation of the fractional sarcoplasmic reticulum Ca2+ release in intact cardiomyocytes using integrated Ca2+ fluxes. Gen. Physiol. Biophys. 2012, 31, 401–408. [Google Scholar] [CrossRef]
  17. Wagner, E.; Lauterbach, M.A.; Kohl, T.; Westphal, V.; Williams, G.S.B.; Steinbrecher, J.H.; Streich, J.-H.; Korff, B.; Tuan, H.-T.M.; Hagen, B.; et al. Stimulated Emission Depletion Live-Cell Super-Resolution Imaging Shows Proliferative Remodeling of T-Tubule Membrane Structures After Myocardial Infarction. Circ. Res. 2012, 111, 402–414. [Google Scholar] [CrossRef]
  18. Arai, M.; Matsui, H.; Periasamy, M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ. Res. 1994, 74, 555–564. [Google Scholar] [CrossRef]
  19. Hasenfuss, G.; Pieske, B. Calcium Cycling in Congestive Heart Failure. J. Mol. Cell. Cardiol. 2002, 34, 951–969. [Google Scholar] [CrossRef]
  20. Li, G.R.; Lau, C.P.; Leung, T.K.; Nattel, S. Ionic current abnormalities associated with prolonged action potentials in cardiomyocytes from diseased human right ventricles. Heart Rhythm. 2004, 1, 460–468. [Google Scholar] [CrossRef]
  21. Chiamvimonvat, N.; Chen-Izu, Y.; Clancy, C.E.; Deschenes, I.; Dobrev, D.; Heijman, J.; Izu, L.; Qu, Z.; Ripplinger, C.M.; Vandenberg, J.I.; et al. Potassium currents in the heart: Functional roles in repolarization, arrhythmia and therapeutics. J. Physiol. 2017, 595, 2229–2252. [Google Scholar] [CrossRef] [PubMed]
  22. Holzem, K.M.; Gomez, J.F.; Glukhov, A.V.; Madden, E.J.; Koppel, A.C.; Ewald, G.A.; Trenor, B.; Efimov, I.R. Reduced response to IKr blockade and altered hERG1a/1b stoichiometry in human heart failure. J. Mol. Cell. Cardiol. 2016, 96, 82–92. [Google Scholar] [CrossRef]
  23. Weber, C.R.; Piacentino, V.; Houser, S.R.; Bers, D.M. Dynamic Regulation of Sodium/Calcium Exchange Function in Human Heart Failure. Circulation 2003, 108, 2224–2229. [Google Scholar] [CrossRef] [PubMed]
  24. Winslow, R.L.; Rice, J.; Jafri, S.; Marbán, E.; O’Rourke, B. Mechanisms of Altered Excitation-Contraction Coupling in Canine Tachycardia-Induced Heart Failure, II. Circ. Res. 1999, 84, 571–586. [Google Scholar] [CrossRef] [PubMed]
  25. Hasenfuss, G.; Schillinger, W.; Lehnart, S.E.; Preuss, M.; Pieske, B.; Maier, L.S.; Prestle, J.; Minami, K.; Just, H. Relationship Between Na+-Ca2+ Exchanger Protein Levels and Diastolic Function of Failing Human Myocardium. Circulation 1999, 99, 641–648. [Google Scholar] [CrossRef] [PubMed]
  26. Meyer, M.; Schillinger, W.; Pieske, B.; Holubarsch, C.; Heilmann, C.; Posival, H.; Kuwajima, G.; Mikoshiba, K.; Just, H.; Hasenfuss, G. Alterations of Sarcoplasmic Reticulum Proteins in Failing Human Dilated Cardiomyopathy. Circulation 1995, 92, 778–784. [Google Scholar] [CrossRef]
  27. Reiken, S.; Gaburjakova, M.; Gaburjakova, J.; He, K.-l.; Prieto, A.; Becker, E.; Yi, G.-h.; Wang, J.; Burkhoff, D.; Marks, A.R. β-Adrenergic Receptor Blockers Restore Cardiac Calcium Release Channel (Ryanodine Receptor) Structure and Function in Heart Failure. Circulation 2001, 104, 2843–2848. [Google Scholar] [CrossRef]
  28. Beuckelmann, D.J.; Näbauer, M.; Erdmann, E. Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ. Res. 1993, 73, 379–385. [Google Scholar] [CrossRef]
  29. Ambrosi, C.M.; Yamada, K.A.; Nerbonne, J.M.; Efimov, I.R. Gender Differences in Electrophysiological Gene Expression in Failing and Non-Failing Human Hearts. PLoS ONE 2013, 8, e54635. [Google Scholar] [CrossRef]
  30. Hasenfuss, G.; Reinecke, H.; Studer, R.; Meyer, M.; Pieske, B.; Holtz, J.; Holubarsch, C.; Posival, H.; Just, H.; Drexler, H. Relation between myocardial function and expression of sarcoplasmic reticulum Ca2+-ATPase in failing and nonfailing human myocardium. Circ. Res. 1994, 75, 434–442. [Google Scholar] [CrossRef]
  31. Li, G.-R.; Lau, C.-P.; Ducharme, A.; Tardif, J.-C.; Nattel, S. Transmural action potential and ionic current remodeling in ventricles of failing canine hearts. Am. J. Physiol. Heart Circ. Physiol. 2002, 283, H1031–H1041. [Google Scholar] [CrossRef] [PubMed]
  32. Spencer, C.I.; Baba, S.; Nakamura, K.; Hua, E.A.; Sears, M.A.; Fu, C.C.; Zhang, J.; Balijepalli, S.; Tomoda, K.; Hayashi, Y.; et al. Calcium transients closely reflect prolonged action potentials in iPSC models of inherited cardiac arrhythmia. Stem Cell Rep. 2014, 3, 269–281. [Google Scholar] [CrossRef] [PubMed]
  33. Song, Z.; Ko, C.Y.; Nivala, M.; Weiss, J.N.; Qu, Z. Calcium-voltage coupling in the genesis of early and delayed afterdepolarizations in cardiac myocytes. Biophys. J. 2015, 108, 1908–1921. [Google Scholar] [CrossRef]
  34. Clusin, W.T. Mechanisms of calcium transient and action potential alternans in cardiac cells and tissues. Am. J. Physiol. Heart Circ. Physiol. 2008, 294, H1–H10. [Google Scholar] [CrossRef]
  35. Vermeulen, J.T.; Mcguire, M.A.; Opthof, T.; Coronel, R.; De Bakker, J.M.T.; Klöpping, C.; Janse, M.J. Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts. Cardiovasc. Res. 1994, 28, 1547–1554. [Google Scholar] [CrossRef]
  36. Janse, M.J. Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc. Res. 2004, 61, 208–217. [Google Scholar] [CrossRef]
  37. Priebe, L.; Beuckelmann, D.J. Simulation study of cellular electric properties in heart failure. Circ. Res. 1998, 82, 1206–1223. [Google Scholar] [CrossRef]
  38. Tomaselli, G.F.; Marbán, E. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc. Res. 1999, 42, 270–283. [Google Scholar] [CrossRef] [PubMed]
  39. Marban, E. Molecular Approaches to Arrhythmogenesis. Molecular Basis of Heart Disease. 1998. Available online: https://www.amazon.com.au/Molecular-Basis-Heart-Disease-Braunwaldss/dp/0721664016 (accessed on 1 October 2024).
  40. Taylor, D.G.; Parilak, L.D.; LeWinter, M.M.; Knot, H.J. Quantification of the rat left ventricle force and Ca2+–Frequency relationships: Similarities to dog and human. Cardiovasc. Res. 2004, 61, 77–86. [Google Scholar] [CrossRef]
  41. Hasenfuss, G. Alterations of calcium-regulatory proteins in heart failure. Cardiovasc. Res. 1998, 37, 279–289. [Google Scholar] [CrossRef]
  42. Pieske, B.; Maier, L.S.; Bers, D.M.; Hasenfuss, G. Ca2+ handling and sarcoplasmic reticulum Ca2+ content in isolated failing and nonfailing human myocardium. Circ. Res. 1999, 85, 38–46. [Google Scholar] [CrossRef] [PubMed]
  43. Lindner, M.; Erdmann, E.; Beuckelmann, D.J. Calcium content of the sarcoplasmic reticulum in isolated ventricular myocytes from patients with terminal heart failure. J. Mol. Cell. Cardiol. 1998, 30, 743–749. [Google Scholar] [CrossRef] [PubMed]
  44. Hobai, I.A.; O’Rourke, B. Decreased sarcoplasmic reticulum calcium content is responsible for defective excitation-contraction coupling in canine heart failure. Circulation 2001, 103, 1577–1584. [Google Scholar] [CrossRef]
  45. Usman, A.; Gandhi, J.; Gupta, G. Physiology, Bowditch Effect. In StatPearls; StatPearls Publishing Copyright© 2023: Treasure Island, FL, USA, 2023. [Google Scholar]
  46. Sobie, E.A.; Ramay, H.R. Excitation-contraction coupling gain in ventricular myocytes: Insights from a parsimonious model. J. Physiol. 2009, 587, 1293–1299. [Google Scholar] [CrossRef]
  47. Shannon, T.R.; Ginsburg, K.S.; Bers, D.M. Potentiation of fractional sarcoplasmic reticulum calcium release by total and free intra-sarcoplasmic reticulum calcium concentration. Biophys. J. 2000, 78, 334–343. [Google Scholar] [CrossRef] [PubMed]
  48. Györke, I.; Györke, S. Regulation of the Cardiac Ryanodine Receptor Channel by Luminal Ca2+ Involves Luminal Ca2+ Sensing Sites. Biophys. J. 1998, 75, 2801–2810. [Google Scholar] [CrossRef]
  49. Sanchez, C.; Berthier, C.; Allard, B.; Perrot, J.; Bouvard, C.; Tsutsui, H.; Okamura, Y.; Jacquemond, V. Tracking the sarcoplasmic reticulum membrane voltage in muscle with a FRET biosensor. J. Gen. Physiol. 2018, 150, 1163–1177. [Google Scholar] [CrossRef]
  50. Altamirano, J.; Bers, D.M. Voltage Dependence of Cardiac Excitation–Contraction Coupling. Circ. Res. 2007, 101, 590–597. [Google Scholar] [CrossRef] [PubMed]
  51. Pogwizd, S.M.; Qi, M.; Yuan, W.; Samarel, A.M.; Bers, D.M. Upregulation of Na+/Ca2+ Exchanger Expression and Function in an Arrhythmogenic Rabbit Model of Heart Failure. Circ. Res. 1999, 85, 1009–1019. [Google Scholar] [CrossRef]
  52. Hart, G. Cellular electrophysiology in cardiac hypertrophy and failure. Cardiovasc. Res. 1994, 28, 933–946. [Google Scholar] [CrossRef]
  53. Näbauer, M.; Kääb, S. Potassium channel down-regulation in heart failure. Cardiovasc. Res. 1998, 37, 324–334. [Google Scholar] [CrossRef] [PubMed]
  54. Wier, W.G.; Egan, T.M.; López-López, J.R.; Balke, C.W. Local control of excitation-contraction coupling in rat heart cells. J. Physiol. 1994, 474, 463–471. [Google Scholar] [CrossRef]
  55. Song, L.-S.; Wang, S.-Q.; Xiao, R.-P.; Spurgeon, H.; Lakatta, E.G.; Cheng, H. β-Adrenergic Stimulation Synchronizes Intracellular Ca2+ Release During Excitation-Contraction Coupling in Cardiac Myocytes. Circ. Res. 2001, 88, 794–801. [Google Scholar] [CrossRef] [PubMed]
  56. Gómez, A.M.; Valdivia, H.H.; Cheng, H.; Lederer, M.R.; Santana, L.F.; Cannell, M.B.; McCune, S.A.; Altschuld, R.A.; Lederer, W.J. Defective Excitation-Contraction Coupling in Experimental Cardiac Hypertrophy and Heart Failure. Science 1997, 276, 800–806. [Google Scholar] [CrossRef]
  57. Stern, M.D. Theory of excitation-contraction coupling in cardiac muscle. Biophys. J. 1992, 63, 497–517. [Google Scholar] [CrossRef] [PubMed]
  58. Györke, S.; Fill, M. Ryanodine Receptor Adaptation: Control Mechanism of Ca2+-Induced Ca2+ Release in Heart. Science 1993, 260, 807–809. [Google Scholar] [CrossRef]
  59. Monte, F.d.; Harding, S.E.; Schmidt, U.; Matsui, T.; Kang, Z.B.; Dec, G.W.; Gwathmey, J.K.; Rosenzweig, A.; Hajjar, R.J. Restoration of Contractile Function in Isolated Cardiomyocytes From Failing Human Hearts by Gene Transfer of SERCA2a. Circulation 1999, 100, 2308–2311. [Google Scholar] [CrossRef]
  60. Cheng, H.; Lederer, W.J.; Cannell, M.B. Calcium sparks: Elementary events underlying excitation-contraction coupling in heart muscle. Science 1993, 262, 740–744. [Google Scholar] [CrossRef]
  61. Williams, G.S.; Chikando, A.C.; Tuan, H.T.; Sobie, E.A.; Lederer, W.J.; Jafri, M.S. Dynamics of calcium sparks and calcium leak in the heart. Biophys. J. 2011, 101, 1287–1296. [Google Scholar] [CrossRef]
  62. Cheng, H.; Lederer, W.J. Calcium Sparks. Physiol. Rev. 2008, 88, 1491–1545. [Google Scholar] [CrossRef]
  63. Kääb, S.; Nuss, H.B.; Chiamvimonvat, N.; O’Rourke, B.; Pak, P.H.; Kass, D.A.; Marban, E.; Tomaselli, G.F. Ionic Mechanism of Action Potential Prolongation in Ventricular Myocytes From Dogs With Pacing-Induced Heart Failure. Circ. Res. 1996, 78, 262–273. [Google Scholar] [CrossRef] [PubMed]
  64. Nuss, H.B.; Kääb, S.; Kass, D.A.; Tomaselli, G.F.; Marbán, E. Cellular basis of ventricular arrhythmias and abnormal automaticity in heart failure. Am. J. Physiol. Heart Circ. Physiol. 1999, 277, H80–H91. [Google Scholar] [CrossRef] [PubMed]
  65. Hoang-Trong, T.M.; Ullah, A.; Jafri, M.S. Calcium Sparks in the Heart: Dynamics and Regulation. Res. Rep. Biol. 2015, 6, 203–214. [Google Scholar] [CrossRef] [PubMed]
  66. Inoue, M.; Bridge, J.H.B. Ca2+ Sparks in Rabbit Ventricular Myocytes Evoked by Action Potentials. Circ. Res. 2003, 92, 532–538. [Google Scholar] [CrossRef]
  67. Poláková, E.; Zahradníková, A., Jr.; Pavelková, J.; Zahradník, I.; Zahradníková, A. Local calcium release activation by DHPR calcium channel openings in rat cardiac myocytes. J. Physiol. 2008, 586, 3839–3854. [Google Scholar] [CrossRef]
  68. Gorski, P.A.; Ceholski, D.K.; Hajjar, R.J. Altered myocardial calcium cycling and energetics in heart failure—A rational approach for disease treatment. Cell Metab. 2015, 21, 183–194. [Google Scholar] [CrossRef]
  69. Brillantes, A.-M.; Allen, P.; Takahashi, T.; Izumo, S.; Marks, A.R. Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy. Circ. Res. 1992, 71, 18–26. [Google Scholar] [CrossRef]
  70. Go, L.O.; Moschella, M.; Watras, J.; Handa, K.; Fyfe, B.; Marks, A. Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J. Clin. Investig. 1995, 95, 888–894. [Google Scholar] [CrossRef]
  71. Sainte Beuve, C.; Allen, P.; Dambrin, G.; Rannou, F.; Marty, I.; Trouve, P.; Bors, V.; Pavie, A.; Gandgjbakch, I.; Charlemagne, D. Cardiac calcium release channel (ryanodine receptor) in control and cardiomyopathic human hearts: mRNA and protein contents are differentially regulated. J. Mol. Cell. Cardiol. 1997, 29, 1237–1246. [Google Scholar] [CrossRef]
  72. Arnáiz-Cot, J.J.; Damon, B.J.; Zhang, X.H.; Cleemann, L.; Yamaguchi, N.; Meissner, G.; Morad, M. Cardiac calcium signalling pathologies associated with defective calmodulin regulation of type 2 ryanodine receptor. J. Physiol. 2013, 591, 4287–4299. [Google Scholar] [CrossRef]
  73. Weiss, J.N.; Garfinkel, A.; Karagueuzian, H.S.; Chen, P.S.; Qu, Z. Early afterdepolarizations and cardiac arrhythmias. Heart Rhythm. 2010, 7, 1891–1899. [Google Scholar] [CrossRef] [PubMed]
  74. Bers, D.M. Calcium Fluxes Involved in Control of Cardiac Myocyte Contraction. Circ. Res. 2000, 87, 275–281. [Google Scholar] [CrossRef] [PubMed]
  75. Takahashi, T.; Allen, P.D.; Lacro, R.V.; Marks, A.R.; Dennis, A.R.; Schoen, F.J.; Grossman, W.; Marsh, J.D.; Izumo, S. Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. J. Clin. Investig. 1992, 90, 927–935. [Google Scholar] [CrossRef]
  76. Sobie, E.A.; Guatimosim, S.; Gómez-Viquez, L.; Song, L.S.; Hartmann, H.; Saleet Jafri, M.; Lederer, W.J. The Ca2+ leak paradox and rogue ryanodine receptors: SR Ca2+ efflux theory and practice. Prog. Biophys. Mol. Biol. 2006, 90, 172–185. [Google Scholar] [CrossRef] [PubMed]
  77. Domeier, T.L.; Blatter, L.A.; Zima, A.V. Alteration of sarcoplasmic reticulum Ca2+ release termination by ryanodine receptor sensitization and in heart failure. J. Physiol. 2009, 587, 5197–5209. [Google Scholar] [CrossRef]
  78. Guo, T.; Ai, X.; Shannon, T.R.; Pogwizd, S.M.; Bers, D.M. Intra-Sarcoplasmic Reticulum Free [Ca2+] and Buffering in Arrhythmogenic Failing Rabbit Heart. Circ. Res. 2007, 101, 802–810. [Google Scholar] [CrossRef]
  79. Shannon, T.R.; Pogwizd, S.M.; Bers, D.M. Elevated Sarcoplasmic Reticulum Ca2+ Leak in Intact Ventricular Myocytes From Rabbits in Heart Failure. Circ. Res. 2003, 93, 592–594. [Google Scholar] [CrossRef]
  80. Kubalova, Z.; Terentyev, D.; Viatchenko-Karpinski, S.; Nishijima, Y.; Györke, I.; Terentyeva, R.; da Cuñha, D.N.Q.; Sridhar, A.; Feldman, D.S.; Hamlin, R.L.; et al. Abnormal intrastore calcium signaling in chronic heart failure. Proc. Natl. Acad. Sci. USA 2005, 102, 14104–14109. [Google Scholar] [CrossRef]
  81. Sjaastad, I.; Wasserstrom, J.A.; Sejersted, O.M. Heart failure—A challenge to our current concepts of excitation-contraction coupling. J. Physiol. 2003, 546, 33–47. [Google Scholar] [CrossRef]
  82. Monsalvo-Villegas, A.; Osornio-Garduño, D.S.; Avila, G. Long-Term Regulation of Excitation-Contraction Coupling and Oxidative Stress in Cardiac Myocytes by Pirfenidone. Front. Physiol. 2018, 9, 1801. [Google Scholar] [CrossRef]
  83. Trafford, A.W.; Díaz, M.E.; Sibbring, G.C.; Eisner, D.A. Modulation of CICR has no maintained effect on systolic Ca2+: Simultaneous measurements of sarcoplasmic reticulum and sarcolemmal Ca2+ fluxes in rat ventricular myocytes. J. Physiol. 2000, 522, 259–270. [Google Scholar] [CrossRef] [PubMed]
  84. Trafford, A.W.; Díaz, M.E.; Eisner, D.A. Coordinated Control of Cell Ca2+ Loading and Triggered Release From the Sarcoplasmic Reticulum Underlies the Rapid Inotropic Response to Increased L-Type Ca2+ Current. Circ. Res. 2001, 88, 195–201. [Google Scholar] [CrossRef] [PubMed]
  85. Tester, D.J.; Ackerman, M.J. Genetics of long QT syndrome. Methodist. Debakey Cardiovasc. J. 2014, 10, 29–33. [Google Scholar] [CrossRef] [PubMed]
  86. Drum, B.M.; Dixon, R.E.; Yuan, C.; Cheng, E.P.; Santana, L.F. Cellular mechanisms of ventricular arrhythmias in a mouse model of Timothy syndrome (long QT syndrome 8). J. Mol. Cell. Cardiol. 2014, 66, 63–71. [Google Scholar] [CrossRef] [PubMed]
  87. Rozanski, G.J.; Xu, Z.; Whitney, R.T.; Murakami, H.; Zucker, I.H. Electrophysiology of rabbit ventricular myocytes following sustained rapid ventricular pacing. J. Mol. Cell. Cardiol. 1997, 29, 721–732. [Google Scholar] [CrossRef] [PubMed]
  88. Wettwer, E.; Amos, G.J.; Posival, H.; Ravens, U. Transient outward current in human ventricular myocytes of subepicardial and subendocardial origin. Circ. Res. 1994, 75, 473–482. [Google Scholar] [CrossRef]
  89. Choi, B.-R.; Li, W.; Terentyev, D.; Kabakov, A.Y.; Zhong, M.; Rees, C.M.; Terentyeva, R.; Kim, T.Y.; Qu, Z.; Peng, X.; et al. Transient Outward K+ Current (Ito) Underlies the Right Ventricular Initiation of Polymorphic Ventricular Tachycardia in a Transgenic Rabbit Model of Long-QT Syndrome Type 1. Circ. Arrhythmia Electrophysiol. 2018, 11, e005414. [Google Scholar] [CrossRef]
  90. Johnson, E.K.; Springer, S.J.; Wang, W.; Dranoff, E.J.; Zhang, Y.; Kanter, E.M.; Yamada, K.A.; Nerbonne, J.M. Differential Expression and Remodeling of Transient Outward Potassium Currents in Human Left Ventricles. Circ. Arrhythmia Electrophysiol. 2018, 11, e005914. [Google Scholar] [CrossRef]
  91. Armendariz-Borunda, J.; Simkevich, C.P.; Roy, N.; Raghow, R.; Kang, A.H.; Seyer, J.M. Activation of Ito cells involves regulation of AP-1 binding proteins and induction of type I collagen gene expression. Biochem. J. 1994, 304, 817–824. [Google Scholar] [CrossRef]
  92. Tsuji, Y.; Opthof, T.; Kamiya, K.; Yasui, K.; Liu, W.; Lu, Z.; Kodama, I. Pacing-induced heart failure causes a reduction of delayed rectifier potassium currents along with decreases in calcium and transient outward currents in rabbit ventricle. Cardiovasc. Res. 2000, 48, 300–309. [Google Scholar] [CrossRef]
  93. Furukawa, T.; Bassett, A.; Furukawa, N.; Kimura, S.; Myerburg, R. The ionic mechanism of reperfusion-induced early afterdepolarizations in feline left ventricular hypertrophy. J. Clin. Investig. 1993, 91, 1521–1531. [Google Scholar] [CrossRef] [PubMed]
  94. Brooksby, P.; Levi, A.J.; Jones, J.V. Investigation of the mechanisms underlying the increased contraction of hypertrophied ventricular myocytes isolated from the spontaneously hypertensive rat. Cardiovasc. Res. 1993, 27, 1268–1277. [Google Scholar] [CrossRef]
  95. Ahmmed, G.U.; Dong, P.H.; Song, G.; Ball, N.A.; Xu, Y.; Walsh, R.A.; Chiamvimonvat, N. Changes in Ca2+ cycling proteins underlie cardiac action potential prolongation in a pressure-overloaded guinea pig model with cardiac hypertrophy and failure. Circ. Res. 2000, 86, 558–570. [Google Scholar] [CrossRef] [PubMed]
  96. Heijman, J.; Voigt, N.; Carlsson, L.G.; Dobrev, D. Cardiac safety assays. Curr. Opin. Pharmacol. 2014, 15, 16–21. [Google Scholar] [CrossRef] [PubMed]
  97. Hennessey, J.A.; Boczek, N.J.; Jiang, Y.-H.; Miller, J.D.; Patrick, W.; Pfeiffer, R.; Sutphin, B.S.; Tester, D.J.; Barajas-Martinez, H.; Ackerman, M.J.; et al. A CACNA1C Variant Associated with Reduced Voltage-Dependent Inactivation, Increased CaV1.2 Channel Window Current, and Arrhythmogenesis. PLoS ONE 2014, 9, e106982. [Google Scholar] [CrossRef] [PubMed]
  98. Coppini, R.; Ferrantini, C.; Yao, L.; Fan, P.; Lungo, M.D.; Stillitano, F.; Sartiani, L.; Tosi, B.; Suffredini, S.; Tesi, C.; et al. Late Sodium Current Inhibition Reverses Electromechanical Dysfunction in Human Hypertrophic Cardiomyopathy. Circulation 2013, 127, 575–584. [Google Scholar] [CrossRef]
  99. Drouin, E.; Charpentier, F.; Gauthier, C.; Laurent, K.; Le Marec, H. Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: Evidence for presence of M cells. J. Am. Coll. Cardiol. 1995, 26, 185–192. [Google Scholar] [CrossRef]
  100. Sicouri, S.; Antzelevitch, C. A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell. Circ. Res. 1991, 68, 1729–1741. [Google Scholar] [CrossRef]
  101. Roden, D.M. Long QT syndrome: Reduced repolarization reserve and the genetic link. J. Intern. Med. 2006, 259, 59–69. [Google Scholar] [CrossRef]
  102. Barr, C.S.; Naas, A.; Freeman, M.; Lang, C.C.; Struthers, A.D. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994, 343, 327–329. [Google Scholar] [CrossRef]
  103. Berger, R.D.; Kasper, E.K.; Baughman, K.L.; Marban, E.; Calkins, H.; Tomaselli, G.F. Beat-to-beat QT interval variability: Novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation 1997, 96, 1557–1565. [Google Scholar] [CrossRef] [PubMed]
  104. Antzelevitch, C. Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H2024–H2038. [Google Scholar] [CrossRef] [PubMed]
  105. Splawski, I.; Shen, J.; Timothy, K.W.; Lehmann, M.H.; Priori, S.; Robinson, J.L.; Moss, A.J.; Schwartz, P.J.; Towbin, J.A.; Vincent, G.M.; et al. Spectrum of Mutations in Long-QT Syndrome Genes. Circulation 2000, 102, 1178–1185. [Google Scholar] [CrossRef] [PubMed]
  106. Passman, R.; Kadish, A. Polymorphic ventricular tachycardia, long q-t syndrome, and torsades de pointes. Med. Clin. N. Am. 2001, 85, 321–341. [Google Scholar] [CrossRef] [PubMed]
  107. Louch, W.E.; Hake, J.; Mørk, H.K.; Hougen, K.; Skrbic, B.; Ursu, D.; Tønnessen, T.; Sjaastad, I.; Sejersted, O.M. Slow Ca2+ sparks de-synchronize Ca2+ release in failing cardiomyocytes: Evidence for altered configuration of Ca2+ release units? J. Mol. Cell. Cardiol. 2013, 58, 41–52. [Google Scholar] [CrossRef]
  108. Vitale, G.; Coppini, R.; Tesi, C.; Poggesi, C.; Sacconi, L.; Ferrantini, C. T-tubule remodeling in human hypertrophic cardiomyopathy. J. Muscle Res. Cell Motil. 2021, 42, 305–322. [Google Scholar] [CrossRef]
  109. Lyon, A.R.; MacLeod, K.T.; Zhang, Y.; Garcia, E.; Kanda, G.K.; Lab, M.J.; Korchev, Y.E.; Harding, S.E.; Gorelik, J. Loss of T-tubules and other changes to surface topography in ventricular myocytes from failing human and rat heart. Proc. Natl. Acad. Sci. USA 2009, 106, 6854–6859. [Google Scholar] [CrossRef]
  110. Lyu, Y.; Verma, V.K.; Lee, Y.; Taleb, I.; Badolia, R.; Shankar, T.S.; Kyriakopoulos, C.P.; Selzman, C.H.; Caine, W.; Alharethi, R.; et al. Remodeling of t-system and proteins underlying excitation-contraction coupling in aging versus failing human heart. NPJ Aging Mech. Dis. 2021, 7, 16. [Google Scholar] [CrossRef]
  111. Seidel, T.; Navankasattusas, S.; Ahmad, A.; Diakos, N.A.; Xu, W.D.; Tristani-Firouzi, M.; Bonios, M.J.; Taleb, I.; Li, D.Y.; Selzman, C.H.; et al. Sheet-Like Remodeling of the Transverse Tubular System in Human Heart Failure Impairs Excitation-Contraction Coupling and Functional Recovery by Mechanical Unloading. Circulation 2017, 135, 1632–1645. [Google Scholar] [CrossRef]
  112. Wei, S.; Guo, A.; Chen, B.; Kutschke, W.; Xie, Y.-P.; Zimmerman, K.; Weiss, R.M.; Anderson, M.E.; Cheng, H.; Song, L.-S. T-Tubule Remodeling During Transition From Hypertrophy to Heart Failure. Circ. Res. 2010, 107, 520–531. [Google Scholar] [CrossRef]
Figure 1. Comparisons of normal cardiac cell conditions vs. heart failure. To ensure steady state conditions, 20 s simulations at 1 Hz were performed. (A) APD prolongation with longer plateau phase due to influx of Ca2+. Early afterdepolarizations (EADs) were also observed through the oscillations of the membrane potential. (B) Ca2+ concentration displays an incomplete extrusion from the myoplasm. (C) RyR2 open probability is decreased during heart failure, and small openings were observed during EAD occurrence. (D) SR Ca2+ also displays incomplete recovery, mainly due to decreased SERCA activity and increased NCX expression.
Figure 1. Comparisons of normal cardiac cell conditions vs. heart failure. To ensure steady state conditions, 20 s simulations at 1 Hz were performed. (A) APD prolongation with longer plateau phase due to influx of Ca2+. Early afterdepolarizations (EADs) were also observed through the oscillations of the membrane potential. (B) Ca2+ concentration displays an incomplete extrusion from the myoplasm. (C) RyR2 open probability is decreased during heart failure, and small openings were observed during EAD occurrence. (D) SR Ca2+ also displays incomplete recovery, mainly due to decreased SERCA activity and increased NCX expression.
Biomolecules 14 01371 g001
Figure 2. Prominent effects of Ito among other K+ currents. (A) APD prolongation from the downregulated repolarizing K+ currents present in failing human cardiomyocytes with decreased Ito (blue) showing a loss of the distinctive “notch” in the action potential shape. (B) Roughly two-fold increase in time-to-peak Ca2+ transient from 0.02 to 0.04 s duration was observed. (C) ILCC peak density also decreased roughly 30–35%, respectively, by the effects of Ito alone. (D) RyR open probability is reduced ~20–25% and (E) delayed kinetics of Ca2+ release from the SR by Ito.
Figure 2. Prominent effects of Ito among other K+ currents. (A) APD prolongation from the downregulated repolarizing K+ currents present in failing human cardiomyocytes with decreased Ito (blue) showing a loss of the distinctive “notch” in the action potential shape. (B) Roughly two-fold increase in time-to-peak Ca2+ transient from 0.02 to 0.04 s duration was observed. (C) ILCC peak density also decreased roughly 30–35%, respectively, by the effects of Ito alone. (D) RyR open probability is reduced ~20–25% and (E) delayed kinetics of Ca2+ release from the SR by Ito.
Biomolecules 14 01371 g002
Figure 3. Dynamic slow–rapid–slow pacing (0.5–2.5–0.5 Hz) [Ca2+]myo concentrations between normal, HF with K+ block (i.e., Ito, IK1, IKr, and IKs), and HF without K+ block. To ensure steady state conditions, 45 s simulations were performed. (A) Erratic Ca2+ transient peaks were observed during 0.5 Hz pacing in failing hearts. HF with reduced K+ currents (red) slightly elevated the [Ca2+]myo amplitude during high pacing (2.5 Hz) as compared to normal (black) and HF without K+ reductions (yellow). (B) Predicted force using the same color schemes. HF with reduced K+ currents (red) exhibit higher predicted force using peak systolic [Ca2+]myo concentrations in rapid pacing.
Figure 3. Dynamic slow–rapid–slow pacing (0.5–2.5–0.5 Hz) [Ca2+]myo concentrations between normal, HF with K+ block (i.e., Ito, IK1, IKr, and IKs), and HF without K+ block. To ensure steady state conditions, 45 s simulations were performed. (A) Erratic Ca2+ transient peaks were observed during 0.5 Hz pacing in failing hearts. HF with reduced K+ currents (red) slightly elevated the [Ca2+]myo amplitude during high pacing (2.5 Hz) as compared to normal (black) and HF without K+ reductions (yellow). (B) Predicted force using the same color schemes. HF with reduced K+ currents (red) exhibit higher predicted force using peak systolic [Ca2+]myo concentrations in rapid pacing.
Biomolecules 14 01371 g003
Figure 4. Comparisons of normal cardiac cell conditions vs. heart failure. To ensure steady state conditions, 20 s simulations at 1 Hz were performed. (A) Peak RyR2 open probability and (B) L-type calcium channel is generally decreased with each HF-related change, i.e., (1) RyR hyperphosphorylation (blue), (2) downregulated SERCA and increased NCX (green), and (3) combination of both (red) mechanisms. (C) On average, RyR2 open probabilities and (D) L-type calcium channel densities are significantly different from normal conditions in HF-related changes (PANOVA < 0.05). (E) Reductions in SR Ca2+ concentrations, both at systole and diastole, are observed in heart failure. In all cases except Normal, the K+ changes reflect those seen in HF. The legend on the bottom shows the increase or decrease of the different components.
Figure 4. Comparisons of normal cardiac cell conditions vs. heart failure. To ensure steady state conditions, 20 s simulations at 1 Hz were performed. (A) Peak RyR2 open probability and (B) L-type calcium channel is generally decreased with each HF-related change, i.e., (1) RyR hyperphosphorylation (blue), (2) downregulated SERCA and increased NCX (green), and (3) combination of both (red) mechanisms. (C) On average, RyR2 open probabilities and (D) L-type calcium channel densities are significantly different from normal conditions in HF-related changes (PANOVA < 0.05). (E) Reductions in SR Ca2+ concentrations, both at systole and diastole, are observed in heart failure. In all cases except Normal, the K+ changes reflect those seen in HF. The legend on the bottom shows the increase or decrease of the different components.
Biomolecules 14 01371 g004
Figure 5. SR Ca2+ dynamic pacing (0.5–2.5–0.5 Hz) and fractional release. To ensure steady state conditions, 45 s simulations were performed. (A) Normal cardiomyocyte. (B) Due to impaired SERCA to re-sequester Ca2+ back into the SR and accompanied with stronger extrusion of Ca2+ by NCX, SR Ca2+ concentrations stay at 800 µM during 2.5 Hz pacing. (C) Increased RyR sensitivity shows diminished amplitudes between systole and diastole, but still exhibits a staircase effect. (D) the combined effects of three HF-related Ca2+ regulatory proteins display the absence of the Bowditch effect, which could be related to the deficient cardiac output seen in failing hearts. (E) SR Ca2+ fractional release is generally increased in cases of HF, but hyperphosphorylation of RyR2 alone accounts for lower Ca2+ release (blue). In all cases except Normal, the K+ changes reflect those seen in HF. The legend on the bottom shows the increase or decrease of the different components. The computed fractional release from the diastolic and systolic [Ca2+]SR values from simulation results are in the Supplemental Materials: HF Supplementary Materials.rar.
Figure 5. SR Ca2+ dynamic pacing (0.5–2.5–0.5 Hz) and fractional release. To ensure steady state conditions, 45 s simulations were performed. (A) Normal cardiomyocyte. (B) Due to impaired SERCA to re-sequester Ca2+ back into the SR and accompanied with stronger extrusion of Ca2+ by NCX, SR Ca2+ concentrations stay at 800 µM during 2.5 Hz pacing. (C) Increased RyR sensitivity shows diminished amplitudes between systole and diastole, but still exhibits a staircase effect. (D) the combined effects of three HF-related Ca2+ regulatory proteins display the absence of the Bowditch effect, which could be related to the deficient cardiac output seen in failing hearts. (E) SR Ca2+ fractional release is generally increased in cases of HF, but hyperphosphorylation of RyR2 alone accounts for lower Ca2+ release (blue). In all cases except Normal, the K+ changes reflect those seen in HF. The legend on the bottom shows the increase or decrease of the different components. The computed fractional release from the diastolic and systolic [Ca2+]SR values from simulation results are in the Supplemental Materials: HF Supplementary Materials.rar.
Biomolecules 14 01371 g005
Figure 6. Excitation–contraction coupling gain. (A) The amount of SR Ca2+ release (in µM)—hyperphosphorylated RyR2s (blue) generally increase release flux as compared with impaired SERCA and upregulated NCX (green). (B) Peak ICaL (in µA) observed—upregulation of INCX decreases the amount of Ca2+ current (green). However, as RyR2 is 50% more sensitive, more Ca2+ is released from the SR (blue). (C) ECC gain is altered at negative (−40 mV to −25 mV) and at positive potentials (from 15 mV and above). (D) RyR open probabilities (PO,RyR) are statistically insignificant and are also observed in experimental findings by Jiang et al. in failing canine and human hearts [7]. (E) A 50% reduction in SERCA activity accounts for the least Ca2+ sequestration into the SR. (F) Systolic SR Ca2+ levels are decreased in HF due to the decreased SR Ca2+ content and other relative HF conditions. The legend on the bottom shows the increase or decrease of the different components.
Figure 6. Excitation–contraction coupling gain. (A) The amount of SR Ca2+ release (in µM)—hyperphosphorylated RyR2s (blue) generally increase release flux as compared with impaired SERCA and upregulated NCX (green). (B) Peak ICaL (in µA) observed—upregulation of INCX decreases the amount of Ca2+ current (green). However, as RyR2 is 50% more sensitive, more Ca2+ is released from the SR (blue). (C) ECC gain is altered at negative (−40 mV to −25 mV) and at positive potentials (from 15 mV and above). (D) RyR open probabilities (PO,RyR) are statistically insignificant and are also observed in experimental findings by Jiang et al. in failing canine and human hearts [7]. (E) A 50% reduction in SERCA activity accounts for the least Ca2+ sequestration into the SR. (F) Systolic SR Ca2+ levels are decreased in HF due to the decreased SR Ca2+ content and other relative HF conditions. The legend on the bottom shows the increase or decrease of the different components.
Biomolecules 14 01371 g006
Figure 7. Representative sample (0.1% of 20,000 CRUs) of detected calcium sparks in the local subspace from 20 CRUs. Superimposed action potential from pacing at 0.5 Hz depicting relationship between AP and Ca2+ sparks (Nsparks). (A) Ca2+ spark behavior in a normally functioning human AP. Minimal Ca2+ leak was observed in the late phase of the AP during extrusion of Ca2+ ions in cell repolarization. (B) Ca2+ spark behavior in heart failure with superimposed AP in the occurrence of early afterdepolarization (EAD). An increase in diastolic spark rate is evident in the late phase of the action potential, which causes APD prolongation and potential presence of EADs. The different colors in the plots indicate the Ca2+ spark from different CRUs.
Figure 7. Representative sample (0.1% of 20,000 CRUs) of detected calcium sparks in the local subspace from 20 CRUs. Superimposed action potential from pacing at 0.5 Hz depicting relationship between AP and Ca2+ sparks (Nsparks). (A) Ca2+ spark behavior in a normally functioning human AP. Minimal Ca2+ leak was observed in the late phase of the AP during extrusion of Ca2+ ions in cell repolarization. (B) Ca2+ spark behavior in heart failure with superimposed AP in the occurrence of early afterdepolarization (EAD). An increase in diastolic spark rate is evident in the late phase of the action potential, which causes APD prolongation and potential presence of EADs. The different colors in the plots indicate the Ca2+ spark from different CRUs.
Biomolecules 14 01371 g007
Figure 8. Comparisons of spark characteristics between normal and heart failure conditions. (A) Systolic SR Ca2+ levels are decreased in HF. (B) RyR hyperphosphorylation produces more sparks than normal and other HF conditions. (C) Similarly, increased RyR sensitivity prolongs spark duration. (D) Modest differences in average spark peaks in all stated underlying cardiac cell impairment.
Figure 8. Comparisons of spark characteristics between normal and heart failure conditions. (A) Systolic SR Ca2+ levels are decreased in HF. (B) RyR hyperphosphorylation produces more sparks than normal and other HF conditions. (C) Similarly, increased RyR sensitivity prolongs spark duration. (D) Modest differences in average spark peaks in all stated underlying cardiac cell impairment.
Biomolecules 14 01371 g008
Table 1. Normal and heart-failure simulation settings.
Table 1. Normal and heart-failure simulation settings.
ParameterNormalHeart FailureReference
IK1
Inward rectifier potassium current
GK1 = 0.238 mS/µFReduced 56%[20,28]
Ito
Transient outward potassium current
Gto = 0.618 mS/µFReduced 67%[20,28]
IKr
Rapid delayed rectifier potassium current
GKr = 0.0488 mS/µFReduced 20%[22,29]
IKs
Slow delayed rectifier potassium current
GKs = 0.0224 mS/µFReduced 28%[20]
RyR2 sensitivity k r y r + = 14 (unitless)Increased 50%[9,10,27]
Ap
SERCA pump concentration
150 µMReduced 50%[19,30]
INCX
Sodium–calcium exchanger
GNCX = 1000 µA/µFIncreased 100%[23]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Alvarez, J.A.E.; Jafri, M.S.; Ullah, A. Using a Failing Human Ventricular Cardiomyocyte Model to Re-Evaluate Ca2+ Cycling, Voltage Dependence, and Spark Characteristics. Biomolecules 2024, 14, 1371. https://doi.org/10.3390/biom14111371

AMA Style

Alvarez JAE, Jafri MS, Ullah A. Using a Failing Human Ventricular Cardiomyocyte Model to Re-Evaluate Ca2+ Cycling, Voltage Dependence, and Spark Characteristics. Biomolecules. 2024; 14(11):1371. https://doi.org/10.3390/biom14111371

Chicago/Turabian Style

Alvarez, Jerome Anthony E., Mohsin Saleet Jafri, and Aman Ullah. 2024. "Using a Failing Human Ventricular Cardiomyocyte Model to Re-Evaluate Ca2+ Cycling, Voltage Dependence, and Spark Characteristics" Biomolecules 14, no. 11: 1371. https://doi.org/10.3390/biom14111371

APA Style

Alvarez, J. A. E., Jafri, M. S., & Ullah, A. (2024). Using a Failing Human Ventricular Cardiomyocyte Model to Re-Evaluate Ca2+ Cycling, Voltage Dependence, and Spark Characteristics. Biomolecules, 14(11), 1371. https://doi.org/10.3390/biom14111371

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop